Enhancer provides a potential target for ‘undruggable’ MYC in pediatric medulloblastoma
(MEMPHIS, Tenn. – April 22, 2026) Efforts to develop effective therapies for MYC-amplified Group 3 medulloblastoma (G3-MB) are…
Browsing Tag
Medulloblastoma;MYC;extrachromosomal dna;ecDNA;Oncogene
1 post